HEMO CHINA was present at CSA & TISC 2021, this year’s edition of the Annual Scientific Session of Chinese Stroke Association (CSA) and Tiantan International

HEMO BIOENGINEERING LIMITED (“HEMO”), a Singapore-based medical device company with a focus on treating stroke patients, is pleased to announce that its Afentta™ intracranial thrombectomy

Big congratulations go to our HEMO CHINA subsidiary for being recognized as the 18th Top Medical Device Company in this year’s prestigious Future Healthcare VB100